Stem cell factor produced by tumor cells expands myeloid-derived suppressor cells in mice
Abstract Immunotherapy is a novel treatment approach for cancers; however, its therapeutic effects are impeded by myeloid-derived suppressor cells (MDSCs). This study aimed to determine how MDSCs are expanded in cancer hosts. MDSCs were positive for Gr-1 and CD11b. Hepa1-6 hepatoma cells, EL4 lympho...
Guardado en:
Autores principales: | Wei-Chen Lee, Pao-Yueh Hsu, Hsiu-Ying Hsu |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/b0ad083767e84fdfa68c5b579fa74439 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Targeting myeloid-derived suppressor cells for cancer therapy
por: Hongchao Tang, et al.
Publicado: (2021) -
Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards
por: Vincenzo Bronte, et al.
Publicado: (2016) -
In Vitro 3D <i>Staphylococcus aureus</i> Abscess Communities Induce Bone Marrow Cells to Expand into Myeloid-Derived Suppressor Cells
por: Marloes I. Hofstee, et al.
Publicado: (2021) -
Dual Targeting of Multiple Myeloma Stem Cells and Myeloid-Derived Suppressor Cells for Treatment of Chemotherapy-Resistant Multiple Myeloma
por: Fatih M. Uckun, et al.
Publicado: (2021) -
CCL2 produced by pancreatic ductal adenocarcinoma is essential for the accumulation and activation of monocytic myeloid‐derived suppressor cells
por: Haitao Gu, et al.
Publicado: (2021)